Evaluation of Efficacy and Safety of Upfront Weekly Nanoparticle Albumin-bound Paclitaxel for HER2-negative Breast Cancer.
暂无分享，去创建一个
A. Matsui | Y. Iwata | M. Hirata | Y. Okamoto | A. Nagayama | Y. Oishi | Y. Murata | Akihiko Tatibana | N. Suzuki | Y. Hamaguchi